⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001412678

Cato Allen Easley

Reports to the SEC for 2 companies · DURHAM, NC

Transactions

7

Companies

2

Filings

1

CIK

0001412678

Forms 4 and 5

Insider transactions

7 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2011-12-15	VTGNVistagen Therapeutics, Inc.C Conversion	10% Owner	CConversion	+11.4K sh	$9999.44	+$114M	28,497
2011-12-15	VTGNVistagen Therapeutics, Inc. · WarrantX Exercise of In-Money	10% Owner	XExercise of In-Money	−11.4K sh	$0.88	−$9,999.44	28,067
2011-12-15	VTGNVistagen Therapeutics, Inc. · WarrantS Sale	10% Owner	SSale	−6,988 sh	$0.88	−$6,149.44	28,067
2011-12-15	VTGNVistagen Therapeutics, Inc. · WarrantX Exercise of In-Money	10% Owner	XExercise of In-Money	+212K sh	$1.25	+$265K	0
2011-12-15	VTGNVistagen Therapeutics, Inc. · WarrantX Exercise of In-Money	10% Owner	XExercise of In-Money	+2,916 sh	$1.05	+$3,061.8	0
2011-12-15	VTGNVistagen Therapeutics, Inc. · WarrantX Exercise of In-Money	10% Owner	XExercise of In-Money	−46.5K sh	$0.88	−$41K	0
2011-12-15	VTGNVistagen Therapeutics, Inc. · WarrantX Exercise of In-Money	10% Owner	XExercise of In-Money	−163K sh	$1.00	−$163K	0

Recent filings

1

Accepted (ET)
Jan 94
Cato Allen Easley0001412678-12-000001
SEC(opens sec.gov)

Companies

2

Address

4364 SOUTH ALSTON AVENUE

DURHAM, NC, 27713